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Intrauterine adhesion (IUA) is one of the most challenging 
conditions related to fertility, given the occurrence of 
recurrent pregnancy losses and infertility along with the 
difficulty to restore the size and shape of the uterine cavity, 
as well as the endometrial function and the fertility.
Eventually, once the pregnancy is ongoing, some 
problems arise derived from the initial condition. When 
IUA are firm or severe, injury to the endometrium can 
destroy his deepest layers, the endometrial stroma and 
reach the myometrium. Restoring the cavity implies 
resection or destruction of the fibrous tissue that forms 
the adhesion, so leaving myometrial and endometrial scary 
areas with a compromised ability to restore the normal 
endometrium given the altered vascularization of these 
areas. If myometrial adhesions are present, as usual, after 
adhesiolysis, the endometrial basalis layer may not facilitate 
the proliferation of the functionalis layer and allow the 
regrowth of normal endometrium. These areas are coated 
by normal endometrium from adjacent places, so they are 
apparently (hysteroscopically) healthy. However, when the 
placentation process occurs, the placental growing tissue 
may invade deeper this thinned area, giving rise to altered 
placentation problems (AIP) (1).
In this  issue of  ATM ,  Feng  e t  a l .  (2)  present a 
retrospective cohort study in a group of 146 pregnant 
patients in which IUA adhesiolysis had been performed. 
They were compared with a matched control group of 
292 patients without IUA antecedents. They present their 
results concerning the obstetric outcomes of these patients. 
They find an OR of 19.93 (33.6% vs. 2.7%) for AIP (accreta, 
increta and precreta), an OR of 3.78 (11.6% vs. 3.1%) 
for placenta previa (PP) (complete, marginal, partial, and 
low-lying placenta) and an OR of 5 (42.5% vs. 8.6%) for 
retained placenta (RP). One out of every three patients 
had an AIP, including severe cases as placenta increta and 
accreta. Surprisingly, there was no need for any postpartum 
hysterectomy. Apart from the peculiar fact that 45.2% 
(132 patients) in the control group underwent cesarean 
section, the increase in placental alterations (AIP, PP and 
RP) in IUA pregnant women must be highlighted.  
Roy et al., studying a cohort of 36 women with Asherman 
syndrome who become pregnant following hysteroscopic 
adhesiolysis, reports on 4 patients (12.5%) with all types of 
AIP (3).
Yu et al., evaluating reproductive outcomes after 
hysteroscopic adhesiolysis, found that 5 out of 25 (25%) 
pregnant patients, who delivered after hysteroscopic 
adhesiolysis, presented AIP, with 2 hysterectomies due to 
uncontrolled hemorrhage for placenta accreta (4).
Deans, in her series with 93 pregnancies in 79 women, 
had 7 AIP (8.2%), 7 PP (8.2%) and 4 hysterectomies 
(4.7%) (5). Additionally, 13 patients (13.3%) underwent 
manual removal of the placenta and 13 more (13.3%) 
postpartum hemorrhage.
In a retrospective study of 357 women who underwent 
hysteroscopic adhesion resection and were followed for a 
mean of 27±9 months, 11 patients (7.9%) had postpartum 
hemorrhage, including 6 (4.3%) due to adherent placenta 
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and 3 (2.1%) due to placenta accreta (6). 
Surgical trauma to the uterine cavity damages the 
endometrial mucosa. When this trauma reaches the stromal 
layer of the endometrium, the physiological regeneration of 
the endometrium is a little more difficult. When the trauma 
reaches the myometrium (aggressive D&C, adhesiolysis), 
the potential for regeneration is compromised. When a 
pregnancy occurs, the myometrial fibrous scar hinders the 
normal process of placentation, in which cytotrophoblastic 
cells proliferate and differentiate into an invasive phenotype 
that invade (interstitial trophoblast) the maternal decidual 
stroma and the spiral arteries (endovascular trophoblast) of 
the myometrium, giving rise to abnormal implantation and 
its associated problems (accretism, intrauterine fetal growth 
restriction, preterm delivery, etc.). 
The suspicion of AIP must be ruled out prenatally by 
means of sonography or magnetic resonance imaging (MRI), 
although the accuracy of these methods is not perfect and 
the criteria for a reliable diagnosis pre- and post-operatively 
are not uniform. 
In one systematic review and meta-analysis of 20 studies 
of prenatal sonographic identification of AIP, the sensitivity 
was approximately 87%, and specificity was approximately 
98% (7) in patients not blinded to the operator. On the 
other side, in study in which ultrasonographers were 
blinded to the clinical story of the patients the accuracy was 
lower (sensitivity 53%) (8), raising some doubts about the 
ultrasound performance in AIP situations. Even more, the 
sonographic findings are not standardized allowing some 
degree of subjectivity.
MRI is useful for the diagnosis of AIP spectrum. 
However, increased accuracy over sonography is not 
proven. In a recent systematic review and meta-analysis 
of 20 studies with 1,080 pregnant women with ultrasound 
suspicion or presence of clinical risk factors for AIP, MRI 
had a global sensitivity of 94% and a specificity of 97% (9). 
To reach a good accuracy in AIP, it is fundamental that 
the findings of sonography and MRI are assessed jointly and 
interpreted by trained radiologists.
In summary, it is important to be aware of the risk of 
altered placental implantation in those pregnant patients 
with a history of IUAs. The women candidates for 
hysteroscopic adhesiolysis must be thoroughly counselled 
regarding subsequent pregnancy and their risks associated 
before the procedure. Once pregnancy achieved, they 
must be considered as high-risk pregnancy and should 
be surveilled and managed consequently. A thorough 
prenatal diagnosis regarding placentation is essential and an 
appropriate setting for the delivery with advanced resources 
(blood bank, radiological facilities, expert surgeons, and 
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